Company research
CDT Equity Inc.
CIK 1896212Updated Sep 24, 2026
Name history
CONDUIT PHARMACEUTICALS INC. · through Aug 7, 2025Murphy Canyon Acquisition Corp. · through Sep 21, 2023
CDT price & chart
Loading TradingView…
NASDAQ:CDT on TradingView ↗About the company
CDT Equity is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The Company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel therapeutic treatments.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,650,000Source | 4,193,000Source | 7,224,000Source | 137,517,822Source |
| Property, Plant and Equipment, NetUSD | 269,000Source | 40,000Source | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,509,000Source | 554,000Source | 4,228,000Source | 345,777Source |
| Assets, CurrentUSD | 4,379,000Source | 2,715,000Source | 5,733,000Source | 646,639Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,823,000Source | 2,161,000Source | 1,505,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 142,000Source | 263,000Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 12,820,000Source | 10,986,000Source | 7,681,000Source | 5,046,725Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | — | 14,000Source | 7,000Source | — |
| Additional Paid in CapitalUSD | 61,171,000Source | 21,880,000Source | 10,424,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -68,325,000Source | -29,101,000Source | -11,299,000Source | -4,300,492Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -16,000Source | 414,000Source | 411,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | -7,170,000Source | -6,793,000Source | -457,000Source | -4,300,086Source |
| Liabilities and EquityUSD | 5,650,000Source | 4,193,000Source | 7,224,000Source | 137,517,822Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 12,820,000Source | 10,741,000Source | 1,801,000Source | 417,975Source |
| Operating Lease, Liability, CurrentUSD | 115,000Source | 119,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,913,000Source | 1,428,000Source | 215,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | — | 107,000Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,600,000Source | — | — | 43,113Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,500,000Source | — | — | — |
| Short-term InvestmentsUSD | — | 4,200,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,183,000Source | 1,632,000Source | 199,000Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 434,000Source | 1,225,000Source | 215,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | — | -3,005,000Source | -1,449,283,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -15,555,000Source | -9,682,000Source | -7,725,000Source | -1,311,310Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -808,000Source | -43,000Source | 725,000Source | -134,895,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 51,000Source | — | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 106,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 17,422,000Source | 6,067,000Source | 10,929,000Source | 136,503,532Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 955,000Source | -3,674,000Source | 4,228,000Source | 297,222Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | 80,000Source | — | — |
| Additional Financial Items | ||||
| AmortizationUSD | 1,440,000Source | 1,666,000Source | 479,000Source | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 400,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | 929,000Source | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,500,000Source | — | — | — |
| DepreciationUSD | — | 10,000Source | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 100,000Source | 200,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | 16,000Source | 2,000Source | 39,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | -707,000Source | — | — |
| General and Administrative ExpenseUSD | 31,703,000Source | 12,041,000Source | 5,172,000Source | 1,092,682Source |
| Income Tax Expense (Benefit)USD | — | — | — | 374,862Source |
| Investment Income, InterestUSD | — | — | 15,000Source | 1,976,183Source |
| Net Income (Loss) Attributable to ParentUSD | -39,224,000Source | -17,802,000Source | -535,000Source | 398,639Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -39,224,000Source | -17,802,000Source | -535,000Source | — |
| Nonoperating Income (Expense)USD | -2,467,000Source | -2,383,000Source | 4,727,000Source | 1,976,183Source |
| Operating ExpensesUSD | 36,757,000Source | 15,419,000Source | 5,262,000Source | — |
| Other Nonoperating Income (Expense)USD | -2,176,000Source | -890,000Source | 4,923,000Source | — |
| Payments to Acquire InvestmentsUSD | — | — | — | 134,895,000Source |
| Proceeds from Issuance of Common StockUSD | 19,699,000Source | 3,328,000Source | 150,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -36,757,000Source | -15,419,000Source | -5,262,000Source | -1,202,682Source |
| Other Nonoperating Income (Expense)USD | -2,176,000Source | -890,000Source | 4,923,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -39,224,000Source | -17,802,000Source | — | 773,501Source |
| Income Tax Expense (Benefit)USD | — | — | — | 374,862Source |
| Net Income (Loss) Attributable to ParentUSD | -39,224,000Source | -17,802,000Source | -535,000Source | 398,639Source |
| Earnings Per Share, BasicUSD per share | -1,177.89Source | -20.53Source | -0.01Source | — |
| Earnings Per Share, DilutedUSD per share | -1,177.89Source | -20.53Source | -0.09Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 33,300Source | 867,096Source | 66,973,906Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 33,300Source | 867,096Source | 67,893,881Source | — |
| Additional Financial Items | ||||
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 100,000Source | 200,000Source | — | — |
| General and Administrative ExpenseUSD | 31,703,000Source | 12,041,000Source | 5,172,000Source | 1,092,682Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -22,067,000Source | -12,855,000Source | — | — |
| Interest ExpenseUSD | 200,000Source | — | — | 100,000Source |
| Interest Expense, DebtUSD | — | 40,000Source | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | -319,000Source | -1,506,000Source | -211,000Source | — |
| Interest Income, OtherUSD | — | 13,000Source | 15,000Source | — |
| Investment Income, InterestUSD | — | — | 15,000Source | 1,976,183Source |
| Investment Income, NetUSD | 28,000Source | 13,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -39,224,000Source | -17,802,000Source | -535,000Source | — |
| Nonoperating Income (Expense)USD | -2,467,000Source | -2,383,000Source | 4,727,000Source | 1,976,183Source |
| Operating ExpensesUSD | 36,757,000Source | 15,419,000Source | 5,262,000Source | — |
| Other ExpensesUSD | 6,000Source | — | — | — |
| Other IncomeUSD | — | 7,000Source | 115,000Source | — |
| Research and Development ExpenseUSD | 5,054,000Source | 3,378,000Source | 90,000Source | — |
Offerings
Registration 333-298808
Filing attachments
ex4-1.htm · 8-K · 2026-09-18
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex107.htm · S-1 · 2026-09-08
Calculation of Filing Fee Tables S-1 CDT Equity Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Pric…
Read attachment ↗ex4-1.htm · 8-K · 2026-09-04
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES ACT ”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL…
Read attachment ↗ex99-1.htm · 8-K/A · 2026-08-21
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SARBORG LIMITED INDEX TO FINANCIAL STATEMENTS Page Audited Financial Statements of Sarborg Limited: Report of Independent Registered Public Accounting Firm 2 Balance Sheets as of December 31, …
Read attachment ↗ex99-2.htm · 8-K/A · 2026-08-21
EX-99.2 3 ex99-2.htm EX-99.2 Exhibit 99.2 SARBORG LIMITED INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS Page Unaudited Condensed Financial Statements of Sarborg Limited: Unaudited Condensed Balance Sheets as of June 30, 2026 and December 31, 2025 2 Unaudited Condensed Statements of Operations for the six months ended June 30, 2026 and 2025 …
Read attachment ↗ex99-1.htm · 8-K/A · 2026-08-21
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SARBORG LIMITED INDEX TO FINANCIAL STATEMENTS Page Audited Financial Statements of Sarborg Limited: Report of Independent Registered Public Accounting Firm 2 Balance Sheets as of December 31, …
Read attachment ↗